methotrexate 25 mg/ml injection
pliva ljubljana d.o.o., ljubljana - raztopina za injiciranje - metotreksat
methotrexate pliva koncentrat za pripravo raztopine za infundiranje 1000 mg
koncentrat za raztopino za infundiranje - metotreksat
methotrexate pliva raztopina za injiciranje 5 mg
raztopina za injiciranje - metotreksat
methotrexate pliva raztopina za injiciranje 50 mg
raztopina za injiciranje - metotreksat
methotrexate pliva raztopina za injiciranje 20 mg
raztopina za injiciranje - metotreksat
xeljanz
pfizer europe ma eeig - tofacitinib - artritis, revmatoidni - imunosupresivi - rheumatoid arthritistofacitinib in combination with methotrexate (mtx) is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (dmards) (see section 5. tofacitinib can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate (see sections 4. 4 in 4. psoriatic arthritistofacitinib in combination with mtx is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (dmard) therapy (see section 5. ulcerative colitistofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5. tofacitinib is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (psa) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (dmards). tofacitinib can be given in combination with methotrexate (mtx) or as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. ankylosing spondylitistofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (as) who have responded inadequately to conventional therapy.
methotrexate ebewe 10 mg/ml raztopina za injiciranje
raztopina za injiciranje - metotreksat
methotrexate ebewe 10 mg/ml raztopina za injiciranje
medicopharmacia, d.o.o. - raztopina za injiciranje - metotreksat
methotrexate ebewe 100 mg/ml raztopina za injiciranje
medicopharmacia, d.o.o. - raztopina za injiciranje - metotreksat
methotrexate for injection usp 1g
kemofarmacija d.d. - raztopina za injiciranje - metotreksat